Biomarker Application for Drug Development in Asthma and COPD. Focus on Airway Inflammation in Asthma
Dr. Philip Silkoff is currently a Senior Director in Pulmonary Medicine/Immunology at Centocor R&D Inc. (Johnson and Johnson Pharmaceutical Research and Development.) Previously, he was the Medical Director and an Associate Professor at the National Jewish Medical Research Center and University of Colorado Health Sciences Center, Denver, CO. He was awarded Clinician of the Year at the National Jewish Medical and Research Center for many years. His clinical and research interests are the biomarkers of asthma diagnosis and treatment.
Presentation runs 1 hour and 6 minutes.
Recommended CitationSilkoff, MD, Philip Emanuel, "Biomarker Application for Drug Development in Asthma and COPD. Focus on Airway Inflammation in Asthma" (2011). Pulmonary and Critical Care Medicine, Presentations and Grand Rounds. Presentation 18.